Sat.Aug 12, 2023 - Fri.Aug 18, 2023

article thumbnail

Could Ativan Pose Harm to People Battling Pancreatic Cancer?

Drugs.com

THURSDAY, Aug. 17, 2023 -- Sometimes patients with pancreatic cancer are prescribed the benzodiazepine lorazepam (Ativan) for anxiety, but that may be harming their health. A new study found this treatment was linked to worse outcomes, with shorter.

Treatment 246
article thumbnail

Blue Shield of California drops CVS Caremark in pharmacy benefit overhaul

BioPharma Drive: Drug Pricing

BSCA has kicked CVS Caremark, the largest pharmacy benefit manager in the country, to the curb and is electing to carve out various pharmacy functions with companies like Amazon instead.

Pharmacy 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Upcoming Webinar: Drug Design Trends in the Age of AI

Collaborative Drug

Upcoming Webinar: Drug design trends in the age of AI

Drugs 246
article thumbnail

Transforming flies into degradable plastics

Science Daily: Pharmacology News

Imagine using insects as a source of chemicals to make plastics that can biodegrade later -- with the help of that very same type of bug. That concept is closer to reality than you might expect. Researchers will describe their progress to date, including the isolation and purification of the insect-derived chemicals and their conversion into their bioplastics.

Research 246
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

WHO Monitoring Highly Mutated New Strain of COVID-19, Now Spotted in Michigan

Drugs.com

FRIDAY, Aug. 18, 2023 -- A new COVID variant with very few known cases but many mutations has been swiftly moved into the World Health Organization’s "variant under monitoring" classification. Four known cases of the variant, dubbed BA.2.86, have.

246
246

More Trending

article thumbnail

Drug Discovery Industry Roundup with Barry Bunin — August 15, 2023

Collaborative Drug

Drug Discovery Industry Roundup with Barry Bunin — August 15, 2023

Drugs 246
article thumbnail

ACS Fall 2023 First Disclosures  

Drug Hunter

The First Disclosures sessions at the 2023 ACS Fall Meeting in San Francisco, organized by Nikki Goodwin , presented a variety of new orally available small molecules. The standing room-only sessions were so highly attended that many attendees were unfortunately kicked out due to the fire code. In case you missed any of these exciting molecules, from Scorpion’s mutant-selective PI3Kα inhibitor to Nurix’s CNS-penetrant BTK degrader, here we share the structures and targets of all the novel molecu

article thumbnail

Middle-Aged Americans Are Using Marijuana, Binge-Drinking at Record Levels

Drugs.com

FRIDAY, Aug. 18, 2023 -- Binge-drinking and marijuana use have reached historically high levels among U.S. adults aged 35 to 50, the U.S. National Institutes of Health announced Thursday. For these middle-aged adults, the drugs of choice are.

Drugs 246
article thumbnail

Precision sells lymphoma drug to Imugene in retreat from cell therapy research

BioPharma Drive: Drug Pricing

The struggling biotech also plans to offload other cell therapy assets, including a multiple myeloma therapy, and focus exclusively on gene editing medicines.

Therapies 246
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

CDD Recognized in 2023 Gartner® Life Science Discovery Research

Collaborative Drug

Company Named as a Sample Vendor for SaaS Electronic Lab Notebook San Francisco, CA - August 15, 2023 - Collaborative Drug Discovery (CDD) is proud to announce its recent recognition as a Sample Vendor for Software-as-a-Service (SaaS) Electronic Laboratory Notebook (ELN) in the Gartner Hype Cycle for Life Science Discovery Research, 2023 report. Gartner Hype Cycles provide a graphic representation of the maturity and adoption of technologies and applications, and how they are potentially relevan

Science 245
article thumbnail

More LRRK2 On-Target Toxicity?

Drug Hunter

LRRK2 has been a hotly pursued drug target for Parkinson’s Disease based on human genetics. Clinical advancement of LRRK2 inhibitors was initially stalled by concerns about on-target lung findings in primates, but these were ameliorated by a Merck/Genentech/Pfizer/MJFF study showing that these lung changes were reversible, and Biogen/Denali has currently a small molecule (BIIB122/DNL151) in Ph.

article thumbnail

Blinded by Chemical Burns, Patients Regained Sight With New Stem Cell Therapy

Drugs.com

FRIDAY, Aug. 18, 2023 -- Phillip Durst was working near an industrial dishwasher when something went awry, and the machinery spewed caustic chemicals into his eyes. “If I had been standing a foot left or right, it wouldn't have hit me right where.

Therapies 246
article thumbnail

Radiopharmaceuticals for cancer: Making radiation precise

BioPharma Drive: Drug Pricing

More than a dozen startups have joined a few publicly traded biotechs and larger pharmaceutical firms in what’s become one of the most competitive areas in drug research.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

CDD Recognized in 2023 Gartner® Hype Cycle™ for Life Science Discovery Research

Collaborative Drug

Company Named as a Sample Vendor for SaaS Electronic Lab Notebook San Francisco, CA - August 15, 2023 - Collaborative Drug Discovery (CDD) is proud to announce its recent recognition as a Sample Vendor for Software-as-a-Service (SaaS) Electronic Laboratory Notebook (ELN) in the Gartner Hype Cycle for Life Science Discovery Research, 2023 report. Gartner Hype Cycles provide a graphic representation of the maturity and adoption of technologies and applications, and how they are potentially relevan

Science 240
article thumbnail

Spear thrower weapon use by prehistoric females equalized the division of labor while hunting

Science Daily: Pharmacology News

A new study has demonstrated that the atlatl (i.e. spear thrower) functions as an 'equalizer', a finding which supports women's potential active role as prehistoric hunters.

190
190
article thumbnail

Flesh-Eating Bacteria Kills 3 People in Connecticut, New York

Drugs.com

THURSDAY, Aug. 17, 2023 -- Public health officials are warning people about the risks of flesh-eating bacterial infections and how to avoid them after the deaths of three older adults on the northeast coast. Two of the deaths from vibriosis — an.

246
246
article thumbnail

FDA lifts hold on Arcellx’s Gilead-partnered cancer cell therapy

BioPharma Drive: Drug Pricing

The agency had paused testing after a patient death, but is now permitting more types of bridging treatment to help keep participants’ disease at bay.

Therapies 246
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Multi-omic stratification of the missense variant cysteinome [@Keribackus]

Covalent Modifiers

Heta S Desai, Samuel Ofori, Lisa M Boatner, Fengchao Yu, Miranda Villaneuva, Nicholas Ung, Alexey Nesvizhskii, Keriann M Backus doi: [link] Cancer genomes are rife with genetic variants; one key outcome of this variation is gain-of-cysteine, which is the most frequently acquired amino acid due to missense variants in COSMIC. Acquired cysteines are both driver mutations and sites targeted by precision therapies.

article thumbnail

Demon Hunting: Physicists confirm 67-year-old prediction of massless, neutral composite particle

Science Daily: Pharmacology News

In 1956, theoretical physicists predicted that electrons in a solid can do something strange. While they normally have a mass and an electric charge, Pines asserted that they can combine to form a composite particle that is massless, neutral, and does not interact with light. He called this particle a 'demon.' Since then, it has been speculated to play an important role in the behaviors of a wide variety of metals.

190
190
article thumbnail

A New Treatment Option for a Form of Sudden Hair Loss

Drugs.com

THURSDAY, Aug. 17, 2023 -- A new type of medication, JAK inhibitors, can effectively treat moderate to severe alopecia areata, a hair loss condition that has been historically hard to treat. A study of its effectiveness, by Dr. Brett King and Dr.

Treatment 246
article thumbnail

FDA approves bispecific drug from Pfizer for multiple myeloma

BioPharma Drive: Drug Pricing

Elrexfio is the third bispecific antibody cleared to treat the blood cancer, and will compete with other therapies that target the “BCMA” protein on myeloma cells.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Elucidation of the mechanisms and molecular targets of KeChuanLiuWei?Mixture for treatment of severe asthma based on network pharmacology

Chemical Biology and Drug Design

Flow diagram of KCLW's network pharmacology. Abstract KeChuanLiuWei-Mixture (KCLW) is widely used as a Chinese medicine prescription to treat severe asthma. However, the underlying therapeutic mechanism of KCLW remains unclear. In this study, a network pharmacology method was used to identify the chemical constituents of KCLW by the TCMSP database and ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry.

Treatment 100
article thumbnail

Platelets can replicate the benefits of exercise in the brain

Science Daily: Pharmacology News

Researchers have found an injection of a specific blood factor can replicate the benefits of exercise in the brain. They've discovered that platelets secrete a protein, exerkine CXCL4/Platelet factor 4 or PF4, that rejuvenates neurons in aged mice in a similar way to physical exercise. This protein, which is released from platelets after exercise, results in regenerative and cognitive improvements when injected into aged mice.

Research 190
article thumbnail

Ignore That New TikTok Trend: Eating Borax Is Dangerous

Drugs.com

THURSDAY, Aug. 17, 2023 -- Despite what you see on TikTok, don’t consume the laundry powder borax to relieve pain and inflammation or boost bone health. Even though videos on the social media site tout it as a treatment, this substance is not safe.

Treatment 246
article thumbnail

The rise of the new pharma marketer in an evolving commercial model

BioPharma Drive: Drug Pricing

Meet the pharma marketer of the future, primed for personalization and powered by technology.

Marketing 246
article thumbnail

Structural properties and immune?enhancing activities of galactan isolated from red seaweed Grateloupia filicina

Chemical Biology and Drug Design

A water-soluble polysaccharide (GFP) was isolated from Grateloupia filicina and its structure was thoroughly examined. Among the polysaccharides, a purified GFP-1 significantly increased the activation of RAW264.7 cells by releasing nitric oxide (NO) and a variety of cytokines via NF-B and MAPK signaling pathways via TLR-2 and TLR-4 binding receptors.

Research 100